🔴 Citius Pharmaceuticals is trading 5.22% down today as immediate catalyst remains unclear

Citius Pharmaceuticals is trading at $0.73 (-5.22%) after opening-market weakness on August 13, 2026; the immediate catalyst is unclear.

• No fresh company-specific announcement was identified for August 13.
• The August 5 LYMPHIR update reported stronger institutional ordering and vial demand, but predates today’s decline.
• The stock is moving against broader risk-on market conditions.